CCO Conference Highlights from the 2020 ESMO Virtual Congress

September 19-21, 2020; Virtual Conference
Download this summary slideset that includes key data from studies in breast, lung, genitourinary, and gastrointestinal cancers presented at the 2020 ESMO Virtual Congress.
Yelena Y. Janjigian, MD
Joyce O'Shaughnessy, MD
Elizabeth R. Plimack, MD, MS
person default
Vamsidhar Velcheti, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.86 MB
Released: October 23, 2020


Supported by an educational grant from
Bristol-Myers Squibb

Related Content

Downloadable slideset from Dr Elizabeth R. Plimack on first-line treatment options for patients with RCC, from Clinical Care Options (CCO)

Elizabeth R. Plimack, MD, MS Released: June 16, 2021

EHR data analysis from ASCO 2021 showed that NGS testing and clinical trial participation were less likely among Black patients with NSCLC than White patients, as reported by Clinical Care Options (CCO)

Released: June 15, 2021

Updated analysis of rate of bone fractures in phase III EORTC GUCG 1333/PEACE-3 trial with or without BPAs from ASCO 2021, as reported by Clinical Care Options (CCO)

Released: June 15, 2021

Downloadable slideset covering PARP inhibitor monotherapy and determinants of response in metastatic CRPC, from Clinical Care Options (CCO)

person default Wassim Abida, MD, PhD Released: June 15, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.